185 related articles for article (PubMed ID: 11702957)
1. Prevalence of complementary and alternative medicine use in cancer patients.
Bernstein BJ; Grasso T
Oncology (Williston Park); 2001 Oct; 15(10):1267-72; discussion 1272-8, 1283. PubMed ID: 11702957
[TBL] [Abstract][Full Text] [Related]
2. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials.
Dy GK; Bekele L; Hanson LJ; Furth A; Mandrekar S; Sloan JA; Adjei AA
J Clin Oncol; 2004 Dec; 22(23):4810-5. PubMed ID: 15570083
[TBL] [Abstract][Full Text] [Related]
3. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
Ezeome ER; Anarado AN
BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
[TBL] [Abstract][Full Text] [Related]
4. Use of complementary and alternative medicine among cancer patients in Israel.
Pud D; Kaner E; Morag A; Ben-Ami S; Yaffe A
Eur J Oncol Nurs; 2005 Jun; 9(2):124-30. PubMed ID: 15944105
[TBL] [Abstract][Full Text] [Related]
5. Complementary and alternative medicine use in colorectal cancer patients in seven European countries.
Molassiotis A; Fernandez-Ortega P; Pud D; Ozden G; Platin N; Hummerston S; Scott JA; Panteli V; Gudmundsdottir G; Selvekerova S; Patiraki E; Kearney N
Complement Ther Med; 2005 Dec; 13(4):251-7. PubMed ID: 16338195
[TBL] [Abstract][Full Text] [Related]
6. Complementary and alternative medications consumed by renal patients in southern Germany.
Nowack R; Ballé C; Birnkammer F; Koch W; Sessler R; Birck R
J Ren Nutr; 2009 May; 19(3):211-9. PubMed ID: 19251442
[TBL] [Abstract][Full Text] [Related]
7. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway.
Opheim R; Bernklev T; Fagermoen MS; Cvancarova M; Moum B
Scand J Gastroenterol; 2012 Dec; 47(12):1436-47. PubMed ID: 23003678
[TBL] [Abstract][Full Text] [Related]
8. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
Chrystal K; Allan S; Forgeson G; Isaacs R
N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
[TBL] [Abstract][Full Text] [Related]
9. Complementary treatments for tobacco cessation: a survey.
Sood A; Ebbert JO; Sood R; Stevens SR
Nicotine Tob Res; 2006 Dec; 8(6):767-71. PubMed ID: 17132524
[TBL] [Abstract][Full Text] [Related]
10. Use of alternative and complementary therapies in children with cancer.
Martel D; Bussières JF; Théorêt Y; Lebel D; Kish S; Moghrabi A; Laurier C
Pediatr Blood Cancer; 2005 Jun; 44(7):660-8. PubMed ID: 15714446
[TBL] [Abstract][Full Text] [Related]
11. Complementary and alternative medicine use during early pregnancy.
Pallivalappila AR; Stewart D; Shetty A; Pande B; Singh R; Mclay JS
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():251-5. PubMed ID: 25190299
[TBL] [Abstract][Full Text] [Related]
12. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy.
Swarup AB; Barrett W; Jazieh AR
Am J Clin Oncol; 2006 Oct; 29(5):468-73. PubMed ID: 17023781
[TBL] [Abstract][Full Text] [Related]
13. Complementary and alternative medicine use among health plan members. A cross-sectional survey.
Gray CM; Tan AW; Pronk NP; O'Connor PJ
Eff Clin Pract; 2002; 5(1):17-22. PubMed ID: 11878283
[TBL] [Abstract][Full Text] [Related]
14. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.
Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE
Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594
[TBL] [Abstract][Full Text] [Related]
15. Use of complementary and alternative medicine for eye-related diseases and conditions.
Bromfield SG; McGwin G
Curr Eye Res; 2013 Dec; 38(12):1283-7. PubMed ID: 23972126
[TBL] [Abstract][Full Text] [Related]
16. Use of complementary and alternative medicine in patients with cancer: a UK survey.
Scott JA; Kearney N; Hummerston S; Molassiotis A
Eur J Oncol Nurs; 2005 Jun; 9(2):131-7. PubMed ID: 15944106
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience.
Naing A; Stephen SK; Frenkel M; Chandhasin C; Hong DS; Lei X; Falchook G; Wheler JJ; Fu S; Kurzrock R
Cancer; 2011 Nov; 117(22):5142-50. PubMed ID: 21538342
[TBL] [Abstract][Full Text] [Related]
18. Complementary and alternative medicine (CAM) among hospitalised patients: reported use of CAM and reasons for use, CAM preferred during hospitalisation, and the socio-demographic determinants of CAM users.
Shorofi SA
Complement Ther Clin Pract; 2011 Nov; 17(4):199-205. PubMed ID: 21982133
[TBL] [Abstract][Full Text] [Related]
19. Use of complementary medicine by adult patients participating in cancer clinical trials.
Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
[TBL] [Abstract][Full Text] [Related]
20. Complementary and alternative medicine use among patients undergoing otolaryngologic surgery.
Shakeel M; Newton JR; Ah-See KW
J Otolaryngol Head Neck Surg; 2009 Jun; 38(3):355-61. PubMed ID: 19476768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
